Boston Cancer Policy Institute

What Boston Cancer Policy Institute does

Boston Cancer Policy Institute, Inc is an independent noncommercial research institute incorporated in Massachusetts in 2012 and based in Somerville, MA. It conducts policy-oriented social sciences research focused on the organizational, managerial, and governance aspects of translational sciences, with a historical origin in precision cancer medicine that has since broadened to include societal and environmental factors affecting cancer and other severe illnesses. The institute operates three scholarly research programs — Governance and Management Frameworks of Translational Science, Frameworks for Scientific Knowledge Production and Diffusion for Sustainability, and Research Policies and Governance Modality — producing peer-reviewed books (via Palgrave Macmillan/Springer), journal articles (including in the Journal of Public Affairs), and conference presentations at forums such as the Society for the Advancement of Socio-Economics, the World Open Innovation Conference, and the Academy of Management. Clinical and laboratory research are explicitly out of scope.

The institute is governed by a board chaired by Joseph A. Richmond, CPA, with Ellie Okada, Ph.D. serving as President and Senior Academic Fellow and effectively as the sole producing scholar. It does not sell products or services, has no pricing model, and reports no commercial revenue or customer base; funding sources are not disclosed in available data. Its distribution channels are exclusively academic — peer-reviewed publishing and conference presentations — and its "customers" are the broader academic, scientific, and policy-making community rather than paying buyers. With 1-10 employees, no offices disclosed beyond the Somerville headquarters, and no disclosed venture, philanthropic, or grant funding, the institute operates as a small, founder-anchored scholarly outfit rather than a scaling organization.

Name

Boston Cancer Policy Institute

Legal name

Boston Cancer Policy Institute, Inc

Website

https://cancerpolicyinstitute.org

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

1–10 employees

Short description

Boston Cancer Policy Institute is an independent nonprofit research institute that conducts policy-oriented social science research on the governance and management of translational sciences, with origins in precision cancer medicine, serving the academic and policy community through peer-reviewed publications and conference presentations.

Ownership category

akta.pro rank

Product category

Cancer Policy Research

NAICS

Research and Development in the Social Sciences and Humanities (541720), Scientific Research and Development Services (5417)

SIC

Books: Publishing Or Publishing & Printing (2731)

akta.pro primary industry

Policy, Regulatory & Public Affairs Research (BPAHALAF)

akta.pro secondary industries

Social Sciences Scholarly Publishing (EDAGAFAD), Public Health Strategy, Policy & Legislation (HLAJAMAA), Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS) (BPAGACAA)

Keywords

• Cancer policy research
• Translational science governance
• Scholarly social science
• Knowledge-intensive organizations
• Science policy frameworks

Headquarters

HQ city

Somerville

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Others

Distribution channels2 records

Marketing channels2 records

Core offering

Boston Cancer Policy Institute conducts policy-oriented scholarly social science research on the organizational, managerial, and governance aspects of translational sciences, cancer therapeutics, and diagnostics. It delivers this work through three research programs producing peer-reviewed books, journal articles, and academic conference presentations rather than selling commercial products or services.

Product overview

Boston Cancer Policy Institute is a noncommercial research institute that conducts policy-oriented research on cancer therapeutics, diagnostics, and translational sciences. The organization offers its scholarly work through published academic books and operates three interconnected research programs: (1) Governance and Management Frameworks of Translational Science, (2) Frameworks for Scientific Knowledge Production and Diffusion for Sustainability, and (3) Research Policies and Governance Modality. These research programs collectively focus on managerial, governance, and social science aspects of translational sciences, producing peer-reviewed publications and presentations as primary deliverables.

Differentiator

Problem solved

Functional benefit

Products and services

• Management of Science-Intensive Organizations: Catalyzing Urban Resilience A peer-reviewed scholarly book authored by Ellie Okada (2021), published by Palgrave Macmillan/Springer International, examining how science-intensive organizations contribute to urban resilience across topics including emerging technologies, environmental inequity, new material sciences, and artificial intelligence applications. Aimed at academic researchers, science policy scholars, and graduate-level students in management and innovation studies.
• Management of Knowledge-Intensive Organizations: Governance Models for Transformative Discovery A peer-reviewed book authored by Ellie Okada (2018/2019), published by Palgrave Macmillan (New York) and Springer (Switzerland), exploring governance models and institutional barriers in knowledge-intensive organizations, including case studies from vaccine science research. Aimed at academic researchers and policy analysts studying translational science governance.

Quantifiable outcome

• Published peer-reviewed books and journal articles contributing to management of knowledge-intensive organizations and translational science governance

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• RAND Corporation: Major nonprofit research institution conducting policy analysis on health, science, and society. Comparable as an independent research nonprofit producing peer-reviewed policy-relevant work, though far larger and more diversified.
• Brookings Institution: Large, established think tank producing policy research across multiple domains including health and science policy. Comparable in its policy-research mission and academic publishing model, but vastly broader in scope, headcount, and funding base.
• Center for Strategic and International Studies: Bipartisan policy research organization producing reports and publications on global policy issues. Comparable as a nonprofit policy research institution with academic-style publishing, though far larger and broader in subject matter.
• Hoover Institution: Public policy research institution producing scholarly books, articles, and policy briefs across economics, governance, and society. Comparable through its academic publishing and policy research model, but operates as a much larger Stanford-affiliated think tank.

Direct peers

• National Bureau of Economic Research: Private, nonprofit research organization producing working papers and scholarly research across economics and adjacent social sciences. Comparable as an independent research nonprofit disseminating academic outputs, though focused on economics rather than science governance.
• Federation of American Scientists: Independent nonprofit that conducts policy-oriented research on science and technology governance. Comparable as a small, mission-driven research organization producing scholarly outputs on how science is organized and governed.
• The Hastings Center: Independent bioethics research institute producing scholarly publications on governance, policy, and societal implications of biomedical science. Closely comparable in scale, nonprofit research model, and focus on the societal/managerial dimensions of biomedical research.

Emerging players

• American Cancer Society: Major cancer-focused nonprofit supporting research, policy, and patient services. Comparable as a cancer-focused nonprofit research organization, though operating at vastly greater scale and oriented toward clinical/research funding rather than social science policy analysis.
• American Association for Cancer Research: Scientific society advancing cancer research through publications, conferences, and policy advocacy. Comparable as a cancer-focused research and policy organization with academic publishing channels, though dominated by clinical/biological research rather than social science.

Others

• Palgrave Macmillan: Academic publisher that has published Boston Cancer Policy Institute's books on science-intensive organizations and knowledge-intensive organizations. Comparable as an enabling partner/distributor of scholarly research rather than a competitor.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/boston-cancer-policy-institute-inc

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Boston Cancer Policy Institute